Compound 11 was moreover capable of reducing the viability of a specific group of RNF43-mutated pancreatic cancer cells (e.g., HPAF-II), whose survival is dependent on functional WNT signaling (10, 39). The gene discussed is RNF43; the disease is pancreatic neoplasm.